Free Trial

Kaltura's (KLTR) "Buy" Rating Reiterated at Needham & Company LLC

→ Dems have chosen Biden replacement? (From Paradigm Press) (Ad)
Kaltura logo with Computer and Technology background

Needham & Company LLC reaffirmed their buy rating on shares of Kaltura (NASDAQ:KLTR - Free Report) in a research note published on Monday, Benzinga reports. The firm currently has a $3.00 price objective on the stock.

Kaltura Price Performance

Shares of NASDAQ KLTR traded up $0.01 during midday trading on Monday, reaching $1.20. 196,554 shares of the company were exchanged, compared to its average volume of 113,142. Kaltura has a one year low of $1.14 and a one year high of $2.27. The stock has a market cap of $175.56 million, a P/E ratio of -3.61 and a beta of 0.73. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.26. The stock's 50-day moving average price is $1.28 and its 200-day moving average price is $1.56.

Kaltura (NASDAQ:KLTR - Get Free Report) last issued its quarterly earnings data on Thursday, February 22nd. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by ($0.07). Kaltura had a negative return on equity of 142.20% and a negative net margin of 25.28%. The company had revenue of $44.48 million for the quarter, compared to the consensus estimate of $41.97 million. During the same quarter last year, the business earned ($0.11) earnings per share. On average, sell-side analysts anticipate that Kaltura will post -0.29 earnings per share for the current fiscal year.


Institutional Trading of Kaltura

Large investors have recently modified their holdings of the stock. Bank of New York Mellon Corp increased its position in Kaltura by 3.6% in the 3rd quarter. Bank of New York Mellon Corp now owns 248,569 shares of the company's stock valued at $430,000 after buying an additional 8,592 shares in the last quarter. Boston Partners increased its holdings in shares of Kaltura by 39.4% during the third quarter. Boston Partners now owns 319,317 shares of the company's stock valued at $552,000 after acquiring an additional 90,198 shares in the last quarter. Acadian Asset Management LLC acquired a new position in shares of Kaltura during the third quarter worth approximately $261,000. SG Americas Securities LLC lifted its holdings in shares of Kaltura by 54.9% in the 4th quarter. SG Americas Securities LLC now owns 19,639 shares of the company's stock worth $38,000 after purchasing an additional 6,957 shares in the last quarter. Finally, Russell Investments Group Ltd. grew its position in Kaltura by 17.3% in the 4th quarter. Russell Investments Group Ltd. now owns 989,537 shares of the company's stock valued at $1,930,000 after purchasing an additional 145,636 shares during the period. Institutional investors and hedge funds own 30.79% of the company's stock.

About Kaltura

(Get Free Report)

Kaltura, Inc provides various software-as-a-service (SaaS) products and solutions and a platform-as-a-service (PaaS) in the United States, Europe, the Middle East, Africa, and internationally. The company operates through two segments, Enterprise, Education, and Technology (EE&T); and Media and Telecom (M&T).

Featured Stories

Should you invest $1,000 in Kaltura right now?

Before you consider Kaltura, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kaltura wasn't on the list.

While Kaltura currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Featured Articles and Offers

Biotech Boom: Stocks Skyrocketing & What's Next

Biotech Boom: Stocks Skyrocketing & What's Next

Dive into biotech's latest trends with Dylan Jovine: weight loss breakthroughs, smart chemo innovations, and expert stock evaluation tips.

Search Headlines: